Stay updated on Clinical Trial: PF-05280014 vs. Trastuzumab/Taxotere+Carboplatin
Sign up to get notified when there's something new on the Clinical Trial: PF-05280014 vs. Trastuzumab/Taxotere+Carboplatin page.

Latest updates to the Clinical Trial: PF-05280014 vs. Trastuzumab/Taxotere+Carboplatin page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision: v3.3.2 was released, replacing v3.3.1, and appears to be a boilerplate platform upgrade with no changes to study content, eligibility criteria, or primary outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check25 days agoChange DetectedAdded a note that PubMed publications are automatically filled from PubMed and may not be about the study. Updated the revision to v3.3.1 and removed the previous PubMed note and revision v3.2.0.SummaryDifference0.1%

- Check32 days agoChange DetectedThe Deletions section removes a government funding lapse notice regarding potential delays and operating status, an administrative banner not related to the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check46 days agoChange DetectedThe screenshots show no changes to core study content such as inclusion criteria, primary/secondary outcomes, or listed locations; only layout/formatting differences are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check76 days agoChange DetectedUpdated the revision label from v3.0.2 to v3.2.0, indicating a newer version has been released. No other content changes observed.SummaryDifference0.1%

- Check77 days agoChange DetectedUpdate indicates a new software/version release (v3.1.0) replacing the previous v3.0.2; no substantive content changes detected.SummaryDifference0.1%

Stay in the know with updates to Clinical Trial: PF-05280014 vs. Trastuzumab/Taxotere+Carboplatin
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: PF-05280014 vs. Trastuzumab/Taxotere+Carboplatin page.